Concepts (173)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Anesthetics | 3 | 2023 | 10 | 2.610 |
Why?
|
| Drug Interactions | 3 | 2021 | 137 | 1.640 |
Why?
|
| Pharmaceutical Preparations | 2 | 2021 | 74 | 1.510 |
Why?
|
| Chronic Disease | 2 | 2021 | 469 | 1.300 |
Why?
|
| Laryngoscopes | 2 | 2016 | 2 | 1.150 |
Why?
|
| Electrocardiography | 3 | 2023 | 154 | 1.140 |
Why?
|
| Coronary Artery Disease | 1 | 2023 | 147 | 0.860 |
Why?
|
| Pain, Postoperative | 7 | 2017 | 22 | 0.730 |
Why?
|
| Laryngoscopy | 2 | 2016 | 6 | 0.710 |
Why?
|
| Intubation, Intratracheal | 2 | 2016 | 22 | 0.710 |
Why?
|
| Pain Measurement | 5 | 2017 | 161 | 0.610 |
Why?
|
| Video-Assisted Surgery | 1 | 2016 | 4 | 0.570 |
Why?
|
| Fiber Optic Technology | 1 | 2016 | 10 | 0.570 |
Why?
|
| Cervical Vertebrae | 1 | 2016 | 14 | 0.570 |
Why?
|
| Postoperative Complications | 3 | 2016 | 206 | 0.540 |
Why?
|
| Betamethasone | 1 | 2015 | 2 | 0.540 |
Why?
|
| Steroids | 1 | 2015 | 43 | 0.520 |
Why?
|
| Anti-Inflammatory Agents | 2 | 2017 | 137 | 0.500 |
Why?
|
| Low Back Pain | 1 | 2015 | 86 | 0.480 |
Why?
|
| Cardiovascular Surgical Procedures | 1 | 2012 | 5 | 0.450 |
Why?
|
| Humans | 27 | 2023 | 34853 | 0.410 |
Why?
|
| Adult | 10 | 2023 | 11034 | 0.350 |
Why?
|
| Ambulatory Surgical Procedures | 3 | 2016 | 6 | 0.340 |
Why?
|
| Postoperative Nausea and Vomiting | 3 | 2020 | 3 | 0.330 |
Why?
|
| Obesity | 1 | 2016 | 965 | 0.320 |
Why?
|
| Equipment Design | 3 | 2016 | 127 | 0.300 |
Why?
|
| Anesthetics, Local | 2 | 2017 | 21 | 0.300 |
Why?
|
| HIV-1 | 1 | 2012 | 678 | 0.290 |
Why?
|
| Prospective Studies | 6 | 2017 | 1353 | 0.290 |
Why?
|
| Arrhythmias, Cardiac | 2 | 2023 | 33 | 0.290 |
Why?
|
| Anesthesia, Conduction | 2 | 2016 | 2 | 0.280 |
Why?
|
| Perioperative Care | 2 | 2016 | 5 | 0.280 |
Why?
|
| Patient Satisfaction | 4 | 2016 | 141 | 0.270 |
Why?
|
| HIV Infections | 3 | 2016 | 2207 | 0.270 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 3 | 2016 | 112 | 0.260 |
Why?
|
| Aged | 7 | 2017 | 6448 | 0.250 |
Why?
|
| Middle Aged | 11 | 2017 | 9642 | 0.250 |
Why?
|
| Antiretroviral Therapy, Highly Active | 3 | 2016 | 219 | 0.250 |
Why?
|
| Magnetic Resonance Imaging | 3 | 2017 | 468 | 0.240 |
Why?
|
| Time Factors | 4 | 2016 | 1681 | 0.230 |
Why?
|
| Female | 14 | 2023 | 19873 | 0.230 |
Why?
|
| Pneumothorax | 1 | 2022 | 9 | 0.230 |
Why?
|
| Heart | 1 | 2023 | 178 | 0.210 |
Why?
|
| United States | 2 | 2021 | 3894 | 0.210 |
Why?
|
| Analgesics, Opioid | 4 | 2016 | 176 | 0.200 |
Why?
|
| Anesthesiology | 1 | 2020 | 6 | 0.190 |
Why?
|
| Midazolam | 2 | 2016 | 3 | 0.180 |
Why?
|
| Anesthetics, Intravenous | 2 | 2016 | 4 | 0.180 |
Why?
|
| Educational Measurement | 1 | 2020 | 80 | 0.180 |
Why?
|
| Aged, 80 and over | 2 | 2016 | 2333 | 0.180 |
Why?
|
| Anxiety | 2 | 2017 | 705 | 0.180 |
Why?
|
| Dexamethasone | 2 | 2017 | 43 | 0.180 |
Why?
|
| Adenosine | 2 | 2017 | 54 | 0.180 |
Why?
|
| Clinical Competence | 1 | 2020 | 124 | 0.180 |
Why?
|
| Male | 13 | 2020 | 18870 | 0.170 |
Why?
|
| Internship and Residency | 1 | 2020 | 121 | 0.170 |
Why?
|
| Anesthesia | 2 | 2016 | 14 | 0.170 |
Why?
|
| Treatment Outcome | 4 | 2015 | 1349 | 0.160 |
Why?
|
| Autonomic Nerve Block | 1 | 2017 | 3 | 0.160 |
Why?
|
| Intercostal Nerves | 1 | 2017 | 2 | 0.160 |
Why?
|
| Analgesia, Epidural | 1 | 2017 | 6 | 0.160 |
Why?
|
| Retrospective Studies | 4 | 2016 | 1961 | 0.150 |
Why?
|
| Manifest Anxiety Scale | 1 | 2017 | 3 | 0.150 |
Why?
|
| Preoperative Period | 1 | 2017 | 8 | 0.150 |
Why?
|
| Interleukin-4 | 1 | 2017 | 69 | 0.150 |
Why?
|
| Facial Expression | 1 | 2017 | 21 | 0.150 |
Why?
|
| Analgesia | 1 | 2016 | 20 | 0.150 |
Why?
|
| Preanesthetic Medication | 1 | 2016 | 1 | 0.150 |
Why?
|
| Coronary Stenosis | 1 | 2017 | 36 | 0.150 |
Why?
|
| Propofol | 1 | 2016 | 8 | 0.150 |
Why?
|
| Carbon Dioxide | 1 | 2017 | 78 | 0.150 |
Why?
|
| Hypnotics and Sedatives | 1 | 2016 | 27 | 0.150 |
Why?
|
| Positron-Emission Tomography | 1 | 2017 | 79 | 0.150 |
Why?
|
| Arthroplasty, Replacement, Knee | 1 | 2016 | 13 | 0.140 |
Why?
|
| Immobilization | 1 | 2016 | 7 | 0.140 |
Why?
|
| Arthroplasty, Replacement, Hip | 1 | 2016 | 12 | 0.140 |
Why?
|
| Mental Recall | 1 | 2016 | 73 | 0.140 |
Why?
|
| Ritonavir | 1 | 2016 | 14 | 0.140 |
Why?
|
| Single-Blind Method | 1 | 2016 | 50 | 0.140 |
Why?
|
| Bariatric Surgery | 1 | 2016 | 14 | 0.140 |
Why?
|
| Double-Blind Method | 5 | 2017 | 269 | 0.140 |
Why?
|
| HIV Protease Inhibitors | 1 | 2016 | 22 | 0.140 |
Why?
|
| Young Adult | 2 | 2016 | 4012 | 0.140 |
Why?
|
| Quality Assurance, Health Care | 1 | 2016 | 55 | 0.140 |
Why?
|
| Hemodynamics | 1 | 2016 | 86 | 0.140 |
Why?
|
| Anesthetics, Dissociative | 1 | 2015 | 1 | 0.140 |
Why?
|
| Injections, Epidural | 1 | 2015 | 1 | 0.140 |
Why?
|
| Sternotomy | 1 | 2015 | 2 | 0.140 |
Why?
|
| Heart, Artificial | 1 | 2015 | 6 | 0.130 |
Why?
|
| Ketamine | 1 | 2015 | 11 | 0.130 |
Why?
|
| Osteoarthritis, Hip | 1 | 2014 | 3 | 0.130 |
Why?
|
| Arthroplasty | 1 | 2014 | 2 | 0.130 |
Why?
|
| Emergency Nursing | 1 | 2014 | 5 | 0.130 |
Why?
|
| Myelography | 1 | 2014 | 1 | 0.130 |
Why?
|
| Spinal Cord Neoplasms | 1 | 2014 | 1 | 0.130 |
Why?
|
| Spinal Puncture | 1 | 2014 | 2 | 0.130 |
Why?
|
| Nursing Staff, Hospital | 1 | 2014 | 10 | 0.130 |
Why?
|
| Spinal Diseases | 1 | 2014 | 20 | 0.130 |
Why?
|
| HIV-Associated Lipodystrophy Syndrome | 1 | 2014 | 31 | 0.130 |
Why?
|
| Hypercapnia | 1 | 2014 | 8 | 0.130 |
Why?
|
| Coronary Circulation | 1 | 2014 | 27 | 0.120 |
Why?
|
| Ventricular Function, Left | 1 | 2014 | 104 | 0.120 |
Why?
|
| Cardiomyopathies | 1 | 2014 | 55 | 0.120 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2014 | 88 | 0.120 |
Why?
|
| Hippocampus | 1 | 2017 | 546 | 0.120 |
Why?
|
| Acupressure | 1 | 2012 | 1 | 0.110 |
Why?
|
| Inflammation | 1 | 2017 | 577 | 0.110 |
Why?
|
| Disposable Equipment | 1 | 2012 | 5 | 0.110 |
Why?
|
| Opioid-Related Disorders | 1 | 2014 | 112 | 0.110 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2015 | 984 | 0.110 |
Why?
|
| Laparoscopy | 1 | 2012 | 54 | 0.100 |
Why?
|
| Cyclooxygenase 2 Inhibitors | 1 | 2010 | 21 | 0.100 |
Why?
|
| Viral Load | 1 | 2012 | 300 | 0.100 |
Why?
|
| Ibuprofen | 1 | 2010 | 33 | 0.100 |
Why?
|
| Pyrazoles | 1 | 2010 | 80 | 0.090 |
Why?
|
| Sulfonamides | 1 | 2010 | 75 | 0.090 |
Why?
|
| Anesthesia Recovery Period | 1 | 2009 | 2 | 0.090 |
Why?
|
| Isoflurane | 1 | 2009 | 3 | 0.090 |
Why?
|
| Methyl Ethers | 1 | 2009 | 2 | 0.090 |
Why?
|
| Anesthesia, Inhalation | 1 | 2009 | 4 | 0.090 |
Why?
|
| Anesthetics, Inhalation | 1 | 2009 | 4 | 0.090 |
Why?
|
| Activities of Daily Living | 3 | 2020 | 104 | 0.090 |
Why?
|
| Cough | 1 | 2009 | 17 | 0.090 |
Why?
|
| Health Personnel | 2 | 2022 | 200 | 0.080 |
Why?
|
| Antiemetics | 2 | 2020 | 7 | 0.080 |
Why?
|
| Vasodilator Agents | 2 | 2017 | 54 | 0.070 |
Why?
|
| Adolescent | 1 | 2016 | 5035 | 0.070 |
Why?
|
| Dogs | 2 | 2017 | 138 | 0.070 |
Why?
|
| Age Factors | 2 | 2016 | 1007 | 0.060 |
Why?
|
| Reproducibility of Results | 2 | 2017 | 901 | 0.050 |
Why?
|
| Chi-Square Distribution | 2 | 2012 | 213 | 0.050 |
Why?
|
| Qualitative Research | 1 | 2022 | 393 | 0.050 |
Why?
|
| Checklist | 1 | 2020 | 10 | 0.050 |
Why?
|
| Aftercare | 1 | 2020 | 18 | 0.050 |
Why?
|
| Goals | 1 | 2020 | 30 | 0.050 |
Why?
|
| Los Angeles | 2 | 2012 | 368 | 0.050 |
Why?
|
| Patient Discharge | 1 | 2020 | 92 | 0.050 |
Why?
|
| Exercise Test | 1 | 2017 | 68 | 0.040 |
Why?
|
| Orthopedic Procedures | 1 | 2016 | 7 | 0.040 |
Why?
|
| Conscious Sedation | 1 | 2016 | 7 | 0.040 |
Why?
|
| Drug Therapy, Combination | 1 | 2017 | 217 | 0.040 |
Why?
|
| Anesthesia, General | 1 | 2016 | 10 | 0.040 |
Why?
|
| Hospitals | 1 | 2016 | 86 | 0.030 |
Why?
|
| Microglia | 1 | 2017 | 152 | 0.030 |
Why?
|
| Prosthesis Implantation | 1 | 2015 | 13 | 0.030 |
Why?
|
| Animals | 3 | 2017 | 14307 | 0.030 |
Why?
|
| Infusions, Intravenous | 1 | 2015 | 48 | 0.030 |
Why?
|
| Sensitivity and Specificity | 1 | 2017 | 555 | 0.030 |
Why?
|
| Professional Misconduct | 1 | 2014 | 2 | 0.030 |
Why?
|
| Spinal Cord Compression | 1 | 2014 | 4 | 0.030 |
Why?
|
| Substance Abuse Detection | 1 | 2014 | 27 | 0.030 |
Why?
|
| Myocardial Contraction | 1 | 2014 | 47 | 0.030 |
Why?
|
| Health Care Surveys | 1 | 2014 | 136 | 0.030 |
Why?
|
| Oximetry | 1 | 2014 | 11 | 0.030 |
Why?
|
| Triglycerides | 1 | 2014 | 129 | 0.030 |
Why?
|
| Image Enhancement | 1 | 2014 | 41 | 0.030 |
Why?
|
| Predictive Value of Tests | 1 | 2014 | 424 | 0.030 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2014 | 281 | 0.030 |
Why?
|
| Ondansetron | 1 | 2012 | 3 | 0.030 |
Why?
|
| Myocardium | 1 | 2014 | 224 | 0.030 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2017 | 1534 | 0.030 |
Why?
|
| Aging | 1 | 2017 | 639 | 0.030 |
Why?
|
| Serotonin Antagonists | 1 | 2012 | 22 | 0.030 |
Why?
|
| Disease Models, Animal | 1 | 2017 | 1300 | 0.030 |
Why?
|
| Combined Modality Therapy | 1 | 2012 | 142 | 0.030 |
Why?
|
| Cohort Studies | 1 | 2016 | 1422 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2014 | 1056 | 0.030 |
Why?
|
| Blood Pressure | 1 | 2015 | 613 | 0.030 |
Why?
|
| Placebo Effect | 1 | 2010 | 13 | 0.020 |
Why?
|
| Italy | 1 | 2010 | 22 | 0.020 |
Why?
|
| Recovery of Function | 1 | 2010 | 89 | 0.020 |
Why?
|
| Administration, Oral | 1 | 2010 | 212 | 0.020 |
Why?
|
| Risk Factors | 1 | 2014 | 3414 | 0.020 |
Why?
|